News
Yourlocation: Home > News > Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

Ten consecutive patients with hypertriglyceridaemia who adhered to a low carbohydrate diet without complete control of serum

 triglycerides were started on chenodeoxycholic acid 750 mg daily and followed monthly for 6 months.

 Nine of these patients were then followed for a further month on placebo capsules and thereafter monthly for a further 6 months on clofibrate 2 g daily. 

2 The mean serum triglyceride level fell by 36% after dietary treatment alone (P less than 0.05) and by 47% from initial values

 on diet plus chenodeoxycholic acid (P less than 0.01). In the nine patients who proceeded to clofibrate therapy there was a 

rise in triglyceride levels on placebo capsules to the level achieved by diet alone, and a further fall on diet plus clofibrate of 47%

of initial values (P less than 0.05). 

3 Chenodeoxycholic acid therapy is effective in the management of hypertriglyceridaemia not

 completely cured by dietary measures, and may be as efficacious as clofibrate.


Address:A3 Building, Dongli Aviation Business District,No.8,Pingying Road, Dongli District, Tianjin, P.R.China, 300300 Tel:+86-022-58602231 Fax:+86-022-58602232 Email:nwsbio@163.com
Copyright © Tianjin NWS Biotechnology and Medicine Co. Ltd.

Reduce
Open